Hypothesis: Macrophages as Effector Cells For Human Tumor Destruction Mediated by Monoclonal Antibody
- 1 January 1983
- journal article
- research article
- Published by Mary Ann Liebert Inc in Hybridoma
- Vol. 2 (1), 1-5
- https://doi.org/10.1089/hyb.1983.2.1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.Proceedings of the National Academy of Sciences, 1982
- A new Fc receptor on mouse macrophages binding IgG3.The Journal of Experimental Medicine, 1981
- Structural evidence for distinct IgG subclass-specific Fc receptors on mouse peritoneal macrophagesThe Journal of Experimental Medicine, 1980
- Colorectal carcinoma antigens detected by hybridoma antibodiesSomatic Cell and Molecular Genetics, 1979
- Monoclonal antibodies in cell‐mediated cytotoxicity against human melanoma and colorectal carcinomaEuropean Journal of Immunology, 1979
- Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.Proceedings of the National Academy of Sciences, 1979
- Reactivity of monoclonal anti‐melanoma antibodies with melanoma cells freshly isolated from primary and metastatic melanomaEuropean Journal of Immunology, 1978
- Study of antibodies against human melanoma produced by somatic cell hybrids.Proceedings of the National Academy of Sciences, 1978
- Receptors for IgG: subclass specificity of receptors on different mouse cell types and the definition of two distinct receptors on a macrophage cell line.The Journal of Experimental Medicine, 1977
- Binding of monomeric immunoglobulins to Fc receptors of mouse macrophages.The Journal of Experimental Medicine, 1975